RxDoctor Payments Data

Susan Delman, MD

Family Medicine · Beachwood, OHNPI 1427261510

Payments from drug & device makers

$1,548in general payments, 2019–2025

Across 79 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$322
  • Lilly USA, LLC$202
  • Novo Nordisk$170
  • Integra Lifesciences Corporation$112
  • AstraZeneca$87
  • GSK$74
  • plus $581 from 16 others

What the payments were for

  • Speaking & faculty fees$735%
  • Food & beverage$1,47595%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,548 in reported general payments places this provider in the 70th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$72,731
Medicare patients
143
Services billed
879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$75,312
MounjaroTirzepatide47$65,993
OzempicSemaglutide47$56,083
JanuviaSitagliptin Phosphate48$51,153
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$44,032
RybelsusSemaglutide33$39,241
JardianceEmpagliflozin35$35,113
FarxigaDapagliflozin Propanediol38$31,260
TrulicityDulaglutide23$30,080
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog24$10,646
Breo ElliptaFluticasone/Vilanterol11$10,169
Atorvastatin Calcium526$6,052
Duloxetine Hcl119$5,764
Rosuvastatin Calcium175$4,819
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$4,385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$202$96,07370 claims
Novo NordiskOzempic, Rybelsus$170$95,32480 claims
PfizerEliquis$72$75,31286 claims
GSKTrelegy Ellipta, Breo Ellipta$74$54,20145 claims
MerckJanuvia$36$51,15348 claims
Boehringer IngelheimJardiance$35$35,11335 claims
AstraZenecaFarxiga$87$31,26038 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$37$4,01911 claims
AbbVieSynthroid$322$1,48061 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Beachwood

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →